Camex

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE198C01010
  • NSEID:
  • BSEID: 524440
INR
32.00
-0.12 (-0.37%)
BSENSE

Feb 09

BSE+NSE Vol: 1.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.09 k (-69.11%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.01%

Held by 0 DIIs

Promoter

44.75%

Who are in the management team of Camex?

06-Jun-2025

As of March 2023, the management team of Camex includes Chandraprakash Chopra (Managing Director), Jitendra Chopra (Whole-time Director), and several Non-Executive & Independent Directors, along with Kruti Shah (Company Secretary) and Rahul Chandraprakash Chopra (Director). This team combines executive leadership with independent oversight.

As of March 2023, the management team of Camex includes the following individuals:<BR><BR>1. Chandraprakash Chopra - Managing Director<BR>2. Jitendra Chopra - Whole-time Director<BR>3. Sunil Tarachand Kothari - Non-Executive & Independent Director<BR>4. Indra Balveermal Singhvi - Non-Executive & Independent Director<BR>5. Kruti Shah - Company Secretary & Compliance Officer<BR>6. Arpit Shah - Non-Executive & Independent Director<BR>7. Rahul Chandraprakash Chopra - Director<BR><BR>This team brings a mix of executive and independent oversight to the company's operations.

View full answer

Has Camex declared dividend?

06-Jun-2025

Camex Ltd has declared a 5% dividend, amounting to $0.5 per share, with an ex-date of September 8, 2014. However, the dividend yield is 0%, indicating it has not contributed to returns in recent periods, despite significant gains over the longer term.

Camex Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 08 Sep 14<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -31.81%, the dividend return was 0%, resulting in a total return of -31.81%.<BR><BR>For the 1-year period, the price return was -13.68%, the dividend return was 0%, leading to a total return of -13.68%.<BR><BR>Over the 2-year period, the price return was 47.96%, the dividend return was 0%, which resulted in a total return of 47.96%.<BR><BR>In the 3-year period, the price return was 48.62%, the dividend return was 0%, culminating in a total return of 48.62%.<BR><BR>For the 4-year period, the price return was 29.24%, the dividend return was 0%, resulting in a total return of 29.24%.<BR><BR>In the 5-year period, the price return was 219.26%, the dividend return was 0%, leading to a total return of 219.26%.<BR><BR>Overall, while Camex Ltd has declared a dividend, the dividend yield remains at 0%, indicating that the dividend has not contributed to returns in recent periods. The total returns show variability, with significant gains over longer periods, particularly in the 5-year span.

View full answer

Who are the peers of the Camex?

03-Jun-2025

Camex's peers include Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, and others. Management risk varies from excellent at GHCL to below average at Camex, with India Glycols showing the highest 1-year return at 150.38%, while Camex has a return of -19.98%.

Peers: The peers of Camex are Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Fischer Medical, Genus Prime, Haryana Leather, Ritesh Intl., Deco-Mica, and TCM.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Chemplast Sanmar, while Average management risk is found at Tata Chemicals, India Glycols, Haryana Leather, and Ritesh Intl., and the rest. Below Average management risk is noted at Fischer Medical, Camex, and TCM, while Genus Prime does not qualify. Growth is classified as Good at Ritesh Intl., Average at Fischer Medical, and Below Average at Tata Chemicals, Chemplast Sanmar, India Glycols, GHCL, Camex, Haryana Leather, Deco-Mica, and TCM, with Genus Prime not qualifying. Capital Structure is Excellent at GHCL, Good at Fischer Medical and Haryana Leather, Average at Tata Chemicals and Ritesh Intl., and Below Average at Chemplast Sanmar, India Glycols, Camex, Deco-Mica, and TCM.<BR><BR>Return Snapshot: India Glycols has the highest 1-year return at 150.38%, while Camex has a 1-year return of -19.98%, which is significantly lower than India Glycols. Additionally, the six-month return is negative for Tata Chemicals, Chemplast Sanmar, GHCL, and TCM.

View full answer

What is the technical trend for Camex?

09-Jun-2025

As of April 22, 2025, Camex's technical trend is mildly bearish, influenced by daily moving averages and mixed signals from MACD and Bollinger Bands, with a mildly bullish stance on the weekly chart and a mildly bearish outlook on the monthly chart.

As of 22 April 2025, the technical trend for Camex has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals. The Bollinger Bands show a bullish outlook on the weekly chart but are mildly bearish on the monthly chart. Moving averages on the daily timeframe are mildly bearish, which aligns with the overall trend. The KST is mildly bullish on the weekly but mildly bearish on the monthly, and Dow Theory supports a mildly bullish view on both timeframes. Overall, the current stance is mildly bearish, driven primarily by the daily moving averages and the mixed signals from MACD and Bollinger Bands.

View full answer

What does Camex do?

17-Jul-2025

Camex Ltd is a micro-cap company in the commodity chemicals sector, specializing in direct dyes for cotton, paper, and leather. As of March 2025, it reported net sales of 372 Cr and a net profit of 2 Cr, with a market cap of INR 42 Cr.

Overview: <BR>Camex Ltd is a micro-cap company in the commodity chemicals industry, specializing in the manufacture of direct dyes used for dyeing cotton, paper, and leather.<BR><BR>History: <BR>Camex Ltd was incorporated in 1989 by Mr. C.P. Chopra and has experienced significant growth with the support of his brother, Mr. Devendra Chopra. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 372 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 2 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 42 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 21.00 <BR>Industry P/E: 35 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.07 <BR>Return on Equity: 4.58% <BR>Price to Book: 0.98 <BR><BR>Contact Details: <BR>Address: Camex House Navrangpura, Stadium 2nd Flr Commerce Road Ahmedabad Gujarat : 380009 <BR>Tel: 91-79-26462123/26462261 <BR>Email: cs@camexltd.com <BR>Website: http://www.camexltd.com

View full answer

Who are the top shareholders of the Camex?

17-Jul-2025

The top shareholders of Camex include Chandraprakash Bhanwarlal Chopra with 18.78%, Rajesh Nahata with 9.74%, and individual investors holding a combined 37.67%. There are no institutional holdings or pledged promoter shares.

The top shareholders of Camex include Chandraprakash Bhanwarlal Chopra, who holds the highest promoter stake at 18.78%. The highest public shareholder is Rajesh Nahata, with a holding of 9.74%. Additionally, individual investors collectively hold 37.67% of the company's shares. There are no institutional holdings or pledged promoter shares reported.

View full answer

How big is Camex?

24-Jul-2025

As of 24th July, Camex Ltd has a market capitalization of 42.00 Cr and reported Net Sales of 146.84 Cr with a Net Profit loss of 0.04 Cr over the latest four quarters. As of March 2022, Shareholder's Funds were 37.17 Cr and Total Assets were 65.03 Cr.

As of 24th July, Camex Ltd has a market capitalization of 42.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Camex reported Net Sales of 146.84 Cr. However, the company experienced a loss of 0.04 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2022, where Shareholder's Funds amounted to 37.17 Cr and Total Assets were valued at 65.03 Cr.

View full answer

When is the next results date for Camex?

07-Aug-2025

Camex will declare its results on 12 August 2025.

Camex will declare its results on 12 August 2025.

View full answer

How has been the historical performance of Camex?

13-Nov-2025

Camex's historical performance shows a decline in net sales from 179.25 Cr in Mar'22 to 146.84 Cr in Mar'23, resulting in a loss with a consolidated net profit of -0.01 Cr compared to 3.18 Cr the previous year. The company faced significant challenges, marked by decreasing profitability and operating income.

Answer:<BR>The historical performance of Camex shows a fluctuating trend in net sales and profitability over the years, culminating in a loss in the most recent fiscal year.<BR><BR>Breakdown:<BR>Camex's net sales decreased from 179.25 Cr in Mar'22 to 146.84 Cr in Mar'23, reflecting a downward trend after a peak of 150.17 Cr in Mar'21. Total operating income followed a similar pattern, dropping to 146.84 Cr in Mar'23 from 179.25 Cr in Mar'22. The company's total expenditure also decreased from 176.78 Cr in Mar'22 to 146.53 Cr in Mar'23, with raw material costs and purchase of finished goods contributing significantly to the overall expenses. Operating profit, excluding other income, fell sharply to 0.31 Cr in Mar'23 from 2.47 Cr in Mar'22, leading to a profit before tax of -0.07 Cr in Mar'23, down from 4.07 Cr in the previous year. Consequently, the profit after tax also turned negative, resulting in a consolidated net profit of -0.01 Cr in Mar'23, compared to 3.18 Cr in Mar'22. The company's earnings per share reflected this downturn, dropping to -0.01 in Mar'23 from 3.11 in Mar'22. Additionally, total assets decreased from 65.03 Cr in Mar'22 to 65.03 Cr in Mar'23, while total liabilities also saw a decline from 65.03 Cr to 65.03 Cr. Overall, Camex's financial performance indicates significant challenges in the latest fiscal year, marked by declining sales and profitability.

View full answer

Is Camex overvalued or undervalued?

14-Nov-2025

As of November 13, 2025, Camex is considered very expensive and overvalued due to its high PE ratio of 69.61, low ROE of 1.18%, and poor stock performance, especially compared to peers like Lloyds Enterprises and PTC India.

As of 13 November 2025, Camex's valuation grade has moved from attractive to very expensive, indicating a significant shift in its market perception. The company is currently overvalued, as evidenced by its high PE ratio of 69.61, an EV to EBITDA ratio of 11.27, and a low ROE of 1.18%. These metrics suggest that the market is pricing in excessive growth expectations that may not be sustainable.<BR><BR>In comparison to its peers, Camex stands out with a notably high PE ratio, especially when compared to Lloyds Enterprises at 29.63 and PTC India at 7.67, both of which are more reasonably valued. The disparity in valuation is further highlighted by Camex's PEG ratio of 0.00, indicating no growth expectations factored into its price, contrasting sharply with the higher ratios of its peers. Additionally, Camex's recent stock performance has been poor, with a year-to-date return of -42.48%, significantly underperforming the Sensex's 8.11% return. This underperformance reinforces the notion that Camex is overvalued in the current market environment.

View full answer

Are Camex Ltd latest results good or bad?

05-Feb-2026

Camex Ltd's latest results show mixed signals, with a 29.81% quarter-on-quarter sales growth but a concerning 30.92% year-on-year decline in stock performance and low profitability metrics. Overall, the financial health raises red flags, suggesting the results are more negative than positive.

Camex Ltd's latest results present a mixed picture, but overall, they indicate significant challenges. In Q3 FY26, the company reported net sales of ₹36.62 crores, reflecting a strong quarter-on-quarter growth of 29.81%. However, this improvement is overshadowed by a year-on-year decline of 30.92% in stock performance, which is considerably worse than both the Sensex and its sector.<BR><BR>While the sequential sales growth is a positive sign, the company's profitability metrics remain concerning. The average Return on Capital Employed (ROCE) is only 6.06%, and the Return on Equity (ROE) is a mere 4.87%, both of which are significantly below industry standards. Additionally, the operating margin stands at just 1.84%, indicating ongoing struggles to generate meaningful profits.<BR><BR>The stock's high P/E ratio of 68 times raises questions about its valuation, especially given the weak fundamentals. Furthermore, the company has shown inconsistent revenue generation and has been unable to maintain positive operating margins consistently.<BR><BR>In summary, while there are some signs of recovery in sales, the broader financial health of Camex Ltd raises red flags, suggesting that the results can be viewed as more negative than positive overall. Investors should approach with caution, considering the structural challenges the company faces.

View full answer

Should I buy, sell or hold Camex Ltd?

06-Feb-2026

Why is Camex Ltd falling/rising?

09-Feb-2026

As of 09-Feb, Camex Ltd's stock price is at 32.00, reflecting a significant decline of 37.06% over the past year. The stock is underperforming its sector and trading below all moving averages, indicating a bearish trend despite increased investor participation.

As of 09-Feb, Camex Ltd's stock price is falling, currently at 32.00, which reflects a decrease of 0.12 or 0.37%. The stock has been underperforming significantly, with a decline of 1.54% over the past week, 5.33% over the past month, and a substantial 37.06% drop over the past year, contrasting sharply with the Sensex, which has shown positive returns in these periods. <BR><BR>Today, the stock has underperformed its sector by 1.85% and has experienced consecutive losses for the last two days, accumulating a total decline of 6.41% in that timeframe. Additionally, Camex Ltd is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. <BR><BR>Despite a rise in investor participation, with delivery volume increasing by 87.74% against the 5-day average, the overall sentiment remains negative, contributing to the stock's decline.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.09%

  • Poor long term growth as Net Sales has grown by an annual rate of 3.00% over the last 5 years
2

Flat results in Dec 25

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 33 Cr (Micro Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

26

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

3.67%

stock-summary
Price to Book

0.74

Revenue and Profits:
Net Sales:
37 Cr
(Quarterly Results - Dec 2025)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.28%
0%
-13.28%
6 Months
-22.42%
0%
-22.42%
1 Year
-37.06%
0%
-37.06%
2 Years
-31.11%
0%
-31.11%
3 Years
13.07%
0%
13.07%
4 Years
-13.75%
0%
-13.75%
5 Years
67.1%
0%
67.1%

Latest dividend: 0.5 per share ex-dividend date: Sep-08-2014

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Resubmitting Unaudited Financial Results For The Quarter And Nine Months Ended On December 312025 Regarding

06-Feb-2026 | Source : BSE

Please refer to the attached Unaudited Financial Results for the Quarter and Nine Months ended on December 31 2025 with the letter of Justifications for the minor typographical error was occurred in the original results was uploaded vide Reference ID : 12068825 dtd.05/02/2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Feb-2026 | Source : BSE

Submission of Newspaper Clippings of the publication of Extract of Unaudited Financial results for the Quarter and Nine Months ended on December 312025

Unaudited Financial Results For The Quarter And Nine Month Ended On December 31 2025

05-Feb-2026 | Source : BSE

Please refer to the attached herewith Unaudited Financial Results for the Quarter and Nine months ended on December 31 2025 alongwith outcome of the Board Meeting which has been approved and adopted by Board of Directors of the Camex Limited in the Meeting of the Board held on February 5 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Camex Ltd has declared 5% dividend, ex-date: 08 Sep 14

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
3.00%
EBIT Growth (5y)
30.81%
EBIT to Interest (avg)
2.03
Debt to EBITDA (avg)
2.08
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
3.02
Tax Ratio
33.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
6.06%
ROE (avg)
4.87%

Valuation key factors

Factor
Value
P/E Ratio
20
Industry P/E
26
Price to Book Value
0.75
EV to EBIT
8.11
EV to EBITDA
6.75
EV to Capital Employed
0.76
EV to Sales
0.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.66%
ROE (Latest)
3.67%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Chandraprakash Bhanwarlal Chopra (18.78%)

Highest Public shareholder

Rajesh Nahata (9.74%)

Individual Investors Holdings

37.52%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 29.81% vs -17.92% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 356.25% vs -127.59% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.62",
          "val2": "28.21",
          "chgp": "29.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.42",
          "val2": "-0.38",
          "chgp": "473.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.26",
          "val2": "0.31",
          "chgp": "-16.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.06",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.82",
          "val2": "-0.32",
          "chgp": "356.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.88%",
          "val2": "-1.35%",
          "chgp": "5.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 4.92% vs -1.61% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -70.05% vs 176.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "71.59",
          "val2": "68.23",
          "chgp": "4.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.68",
          "val2": "2.26",
          "chgp": "-25.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.62",
          "val2": "0.78",
          "chgp": "-20.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.62",
          "val2": "2.07",
          "chgp": "-70.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.35%",
          "val2": "3.31%",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 12.20% vs -7.02% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -17.71% vs -8.38% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "108.21",
          "val2": "96.44",
          "chgp": "12.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.10",
          "val2": "1.88",
          "chgp": "64.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.88",
          "val2": "1.09",
          "chgp": "-19.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.06",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.44",
          "val2": "1.75",
          "chgp": "-17.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.86%",
          "val2": "1.95%",
          "chgp": "0.91%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -5.75% vs 7.39% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -45.38% vs 467.21% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "133.65",
          "val2": "141.81",
          "chgp": "-5.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.94",
          "val2": "4.64",
          "chgp": "-15.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.33",
          "val2": "0.76",
          "chgp": "75.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.07",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.89",
          "val2": "3.46",
          "chgp": "-45.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.95%",
          "val2": "3.27%",
          "chgp": "-0.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
36.62
28.21
29.81%
Operating Profit (PBDIT) excl Other Income
1.42
-0.38
473.68%
Interest
0.26
0.31
-16.13%
Exceptional Items
0.00
-0.06
100.00%
Standalone Net Profit
0.82
-0.32
356.25%
Operating Profit Margin (Excl OI)
3.88%
-1.35%
5.23%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 29.81% vs -17.92% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is 356.25% vs -127.59% in Dec 2024

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
71.59
68.23
4.92%
Operating Profit (PBDIT) excl Other Income
1.68
2.26
-25.66%
Interest
0.62
0.78
-20.51%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.62
2.07
-70.05%
Operating Profit Margin (Excl OI)
2.35%
3.31%
-0.96%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 4.92% vs -1.61% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -70.05% vs 176.00% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
108.21
96.44
12.20%
Operating Profit (PBDIT) excl Other Income
3.10
1.88
64.89%
Interest
0.88
1.09
-19.27%
Exceptional Items
0.00
-0.06
100.00%
Standalone Net Profit
1.44
1.75
-17.71%
Operating Profit Margin (Excl OI)
2.86%
1.95%
0.91%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 12.20% vs -7.02% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -17.71% vs -8.38% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
133.65
141.81
-5.75%
Operating Profit (PBDIT) excl Other Income
3.94
4.64
-15.09%
Interest
1.33
0.76
75.00%
Exceptional Items
-0.07
0.00
Standalone Net Profit
1.89
3.46
-45.38%
Operating Profit Margin (Excl OI)
2.95%
3.27%
-0.32%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -5.75% vs 7.39% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -45.38% vs 467.21% in Mar 2024

stock-summaryCompany CV
About Camex Ltd stock-summary
stock-summary
Camex Ltd
Micro Cap
Commodity Chemicals
Camex Ltd was incorporated in 1989 by Mr. C.P. Chopra in a very humble but with lot of fervor in the textile city of Ahmedabad, in Gujarat. With the dedicated support of his brother Mr. Devendra Chopra, he took the Company to a blazing trail of success. The Company is one of the few dyestuff manufacturers in India, offering direct dyes that are typically used for dyeing cotton, paper, and leather. They are used as pH indicators as well as biological stains.
Company Coordinates stock-summary
Company Details
Camex House Navrangpura, Stadium 2nd Flr Commerce Road Ahmedabad Gujarat : 380009
stock-summary
Tel: 91-79-26462123/26462261
stock-summary
cs@camexltd.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai